神经基因素1受体对抗性作为酒精治疗的可能疗法
David T George1, Jodi Gilman, Jacqueline Hersh
1Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
神经素1受体 (NK1R) 抗性显示出治疗酒精依赖的前景. 阻断NK1R降低了患者的酒精渴望和压力反应,这表明了酒精主义的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 酒精依赖是一个重要的公共卫生问题,有效的治疗方法有限.
- 大脑的压力系统极大地影响了酒精消费和复发.
- 神经素1受体 (NK1R) 调解压力反应,可能在酒中发挥作用.
研究的目的:
- 研究NK1R在酒精依赖中的作用及其作为治疗点的潜力.
- 评估NK1R抗剂在减少酒精摄入量和渴望中的有效性.
主要方法:
- 使用NK1R缺乏的小鼠进行临床前研究,以评估酒精消耗和敏感性.
- 一项随机对照试验,针对最近排毒的酒精性住院患者进行NK1R抗剂 (LY686017) 或安慰剂治疗.
- 使用fMRI评估酒精渴望,幸福感,皮质醇水平和大脑活动.
主要成果:
- 缺乏NK1R的小鼠表现出减少的酒精消耗和增加的酒精诱导镇静.
- LY686017治疗抑制了自发的酒精渴望,并在挑战后抑制了渴望.
- NK1R对抗剂减弱了皮质醇反应,并对对情感刺激的反应对大脑活动产生有益影响.
结论:
- NK1R对抗性显示出作为一种新的酒精依赖治疗策略的潜力.
- 准NK1R可能有助于控制酒精渴望和与压力相关的成成分.
- 对NK1R抗剂的进一步研究对于酒精治疗是有必要的.
更多相关视频
07:50A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
CNS Depressants: Alcohol and Nicotine
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
